AI · 1 sources covering this

Montana’s plan to become an experimental medical hub just pushed forward

As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MIT Technology ReviewCenter·2h ago
Montana’s plan to become an experimental medical hub just pushed forward
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Read at MIT Technology Review →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/bd8466f5afaa13a6d98a4985ca5d54cd6fe033fb"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Montana’s plan to become an experimental medical hub just pushed forward"></iframe>

Montana’s plan to become an experimental medical hub just pushed forward

How 1 sources are covering this